The FDA Guidance on the Assessment of Abuse Potential of Drug – A Critical Review
March 30, 2017 - Toronto ON CAXtalks Life Science Webinars
ecoman@xtalks.com
Phone:416 977 6555 ex 371
The purpose of this webinar is to evaluate and discuss the methodological approaches outlined in the guidance and highlight several key areas that may warrant further consideration when designing and planning for studies involving abuse potential. Guest speakers are industry leaders in the evaluation of preclinical and clinical abuse and dependence evaluation.
This website uses cookies to ensure you get the best experience on our website. Learn more